Pharmaceutical formulations containing 1- (β-D-glucopyranosyl) -2-thienyl-methylbenzene derivatives as inhibitors of SGLT
- 专利权人:
- ヤンセン;ヤンセン ファーマシューティカ エヌ.ベー.;ファーマシューティカ;エヌ．ベー．
- 发明人:
- ワング，ウェンフア,アウトウィン，トッド,ジョセフ，トーマス シー．,ワング,ウェンフア,アウトウィン,トッド,ジョセフ,トーマス シー.
- 申请号：
- JP2013510272
- 公开号：
- JP6227406B2
- 申请日:
- 2011.05.11
- 申请国别(地区):
- JP
- 年份:
- 2017
- 代理人:
- 摘要：
- The present invention relates to formulations including compounds of Formula (I), or prodrug, or a pharmaceutically acceptable salt thereof.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- SGLT 1--D--2-- PHARMACEUTICAL FORMULATIONS COMPRISING 1-BETA-D-GLUCOPYRANOSYL-2-THIENYL-METHYLBENZENE DERIVATIVES AS INHIBITORS OF SGLT
- Pharmaceutical formulations comprising 1- (BETA-D-glucopyranosyl) -2-THIENYLMETHYLBENZEN derivatives as inhibitors of SGLT
- PHARMACEUTICAL FORMULATIONS COMPRISING 1 - (BETA-D-GLUCOPYRANOSYL) - 2 -THIENYLMETHYLBENZENE DERIVATIVES AS INHIBITORS OF SGLT
- PHARMACEUTICAL FORMULATIONS COMPRISING 1-(BETA-D-GLUCOPYRANOSYL)-2-THIENYLMETHYLBENZENE DERIVATIVES AS INHIBITORS OF SGLT
- Pharmaceutical formulations comprising 1 - (beta-D-glucopyranosyl) - 2 -thienylmethylbenzene derivatives as inhibitors of SGLT
